Clinical Trial Update: Folfox-B Study for Patients With Colorectal Liver Metastases [Phase 2]

View source ↗

Summary

A Phase 2 Folfox-B trial for colorectal cancer with liver metastases was terminated, and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Liver Metastases | Phase 2 | Status: TERMINATED | Results posted: 2010-11-04